As techniques have been refined, interest in personalized mouse models of disease has risen, writes Andrew Pollack at The New York Times. While the use of such avatars has not been proven to affect patient outcomes and is expensive, Pollack says that some cancer patients are still trying that approach to learn more about how their cancers, implanted into mice, react to different drugs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Very Own Mouse

The Mouse Version

The Healthiest

This Week in Cell

Order Matters

Fido's Prescription

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.

In Science this week: the Human Silencing Hub protein complex, and more.